Bank of America’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-58,330
| Closed | -$1.98M | – | 6636 |
|
|
2025
Q4 | $1.98M | Buy |
58,330
+54,359
| +1,369% | +$1.69M | ﹤0.01% | 4081 |
|
|
2025
Q3 | $102K | Sell |
3,971
-2,942
| -43% | -$38.5K | ﹤0.01% | 6581 |
|
|
2025
Q2 | $55.3K | Sell |
6,913
-22,996
| -77% | -$175K | ﹤0.01% | 6778 |
|
|
2025
Q1 | $292K | Sell |
29,909
-7,601
| -20% | -$74.7K | ﹤0.01% | 5963 |
|
|
2024
Q4 | $474K | Buy |
37,510
+69
| +0.2% | +$876 | ﹤0.01% | 5574 |
|
|
2024
Q3 | $602K | Buy |
37,441
+26,109
| +230% | +$528K | ﹤0.01% | 5376 |
|
|
2024
Q2 | $277K | Sell |
11,332
-2,325
| -17% | -$107K | ﹤0.01% | 5717 |
|
|
2024
Q1 | $981K | Buy |
13,657
+1,981
| +17% | +$275K | ﹤0.01% | 4945 |
|
|
2023
Q4 | $2.32M | Buy |
11,676
+87
| +0.8% | +$10.8K | ﹤0.01% | 4255 |
|
|
2023
Q3 | $1.54M | Buy |
11,589
+2,401
| +26% | +$392K | ﹤0.01% | 4494 |
|
|
2023
Q2 | $1.37M | Sell |
9,188
-8,217
| -47% | -$1.28M | ﹤0.01% | 4535 |
|
|
2023
Q1 | $2.55M | Sell |
17,405
-493
| -3% | -$99.7K | ﹤0.01% | 4131 |
|
|
2022
Q4 | $2.84M | Buy |
17,898
+11,731
| +190% | +$1.88M | ﹤0.01% | 3942 |
|
|
2022
Q3 | $1.19M | Buy |
6,167
+5,044
| +449% | +$954K | ﹤0.01% | 4749 |
|
|
2022
Q2 | $164K | Sell |
1,123
-3,392
| -75% | -$452K | ﹤0.01% | 6226 |
|
|
2022
Q1 | $794K | Sell |
4,515
-5,764
| -56% | -$1.09M | ﹤0.01% | 5453 |
|
|
2021
Q4 | $3.02M | Buy |
10,279
+9,138
| +801% | +$2.44M | ﹤0.01% | 4158 |
|
|
2021
Q3 | $283K | Buy |
1,141
+154
| +16% | +$40.7K | ﹤0.01% | 6049 |
|
|
2021
Q2 | $250K | Buy |
987
+17
| +2% | +$3.18K | ﹤0.01% | 5944 |
|
|
2021
Q1 | $172K | Buy |
970
+411
| +74% | +$67.8K | ﹤0.01% | 6131 |
|
|
2020
Q4 | $88K | Buy |
559
+94
| +20% | +$20.4K | ﹤0.01% | 6050 |
|
|
2020
Q3 | $120K | Sell |
465
-2,394
| -84% | -$531K | ﹤0.01% | 5588 |
|
|
2020
Q2 | $663K | Buy |
2,859
+2,787
| +3,871% | +$431K | ﹤0.01% | 4414 |
|
|
2020
Q1 | $12K | Buy |
72
+42
| +140% | +$9.57K | ﹤0.01% | 6311 |
|
|
2019
Q4 | $7K | Buy |
+30
| New | +$5.52K | ﹤0.01% | 6708 |
|
Bank of America's RAPT Position: Q1 2026 in Review
Bank of America sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 58,330 shares — an estimated $1.98M sold.
Bank of America first reported a position in RAPT in Q4 2019 and held it in 25 quarters. The position peaked at $3.02M in Q4 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- Bank of America reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 58,330 RAPT Therapeutics shares in Q1 2026, an estimated $1.98M.
- Bank of America first reported a position in RAPT Therapeutics in Q4 2019 and held it in 25 quarters.
- Bank of America's RAPT Therapeutics position peaked at $3.02M in Q4 2021.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.